Breakthrough in Managing Agitated Delirium in Advanced Cancer Patients
A study by The University of Texas MD Anderson Cancer Center reveals that combining haloperidol and lorazepam significantly reduces symptoms of agitated delirium in advanced cancer patients, offering a new approach to improve end-of-life care.